Volumetric bone density, geometry, strength and bone tissue material properties in type 1 diabetes
1 型糖尿病的体积骨密度、几何形状、强度和骨组织材料特性
基本信息
- 批准号:9918247
- 负责人:
- 金额:$ 16.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-10 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressAdultAffectAgeAnimal ModelBiopsyBiopsy SpecimenBody mass indexBone DensityBone TissueBone structureCaringChemicalsClinicalClinical SciencesComplications of Diabetes MellitusDataDeteriorationDevelopmentDiabetes MellitusDoctor of PhilosophyElasticityElderlyElectron MicroscopyElementsEpidemiologyFemurFinancial HardshipFinite Element AnalysisFractureFundingFutureGenderGeometryGoalsGrantHip FracturesHip region structureHumanImageInsulin-Dependent Diabetes MellitusInterventionKnowledgeLiteratureMeasuresMentored Patient-Oriented Research Career Development AwardMentorsModelingMorbidity - disease rateOsteoporosisPatientsPopulationPostmenopausePrevention approachPropertyRaman Spectrum AnalysisReportingResearchResearch PersonnelResearch TechnicsRiskRoentgen RaysSenior ScientistSiteStructureTechniquesTestingTherapeuticTimeTissuesTrainingTranslational ResearchUnited States National Institutes of HealthWomanWorkX-Ray Computed Tomographybasebiomechanical engineeringbonebone agingbone fragilitybone geometrybone healthbone metabolismbone qualitybone strengthcareercareer developmentcomputerizedfallsfracture riskhigh riskhigh risk populationhip boneimprovedindexingmortalitymultimodalitynanoindentationnon-diabeticnovelosteoporosis with pathological fracturepreventskills
项目摘要
Abstract
Postmenopausal women with type 1 diabetes (T1D) have a six- to eight-fold higher risk for hip fractures
compared to women without diabetes. Hip fractures are associated with significant morbidity, mortality, loss of
independence, and financial burden. Moreover, hip fracture mortality is higher in patients with diabetes
compared to subjects without diabetes. Dual x-ray absorptiometry (DXA), the most common test to assess
bone health, measures only areal bone mineral density (BMD), and fails to provide information on bone quality;
hence, it underestimates fracture risk in patients with T1D. Therefore, we hypothesize that hip structural and
bone tissue material quality will be compromised in postmenopausal women with T1D compared to controls.
Consistent with overarching hypothesis, we propose to determine hip bone structural quality (vBMD, bone
geometry, and bone strength) using quantitative computed tomography (QCT) and a novel computerized
image-based technique (finite element analysis) [Aim 1], and evaluate differences in bone tissue composition
and tissue material properties from transiliac bone biopsy using Raman spectroscopy, nanoindentation, and
backscattered electron microscopy [Aim 2] in postmenopausal women with T1D compared to age- and BMI-
matched postmenopausal women without diabetes.
With improved care, people with T1D are living longer and there is no specific approach for prevention and
treatment of osteoporosis for older adults with T1D. Therefore, this study will elucidate possible mechanisms of
bone fragility in postmenopausal women with T1D with the long-term goal to prevent hip fractures and related
morbidity in this high-risk population.
The proposed K23 award will facilitate my transition to independence by providing support necessary to; 1)
acquire and consolidate clinical science knowledge and translational research skills; 2) develop professional
research skills, and 3) develop a path to independent research. To achieve my professional goals, I have
assembled a team of mentors comprised of 1) Dr. Janet Snell-Bergeon, PhD, an expert in the field of T1D
complications and epidemiology, funded by the NIH for more than a decade; and 2) Dr. Wendy Kohrt, PhD, a
senior scientist in the field of bone metabolism and aging, with over three decades of constant NIH funding. In
addition, the expertise of Mentoring team (Dr. Chonchol, clinical researcher in the field of bone metabolism,
Drs. Carpenter and Ferguson, biomechanical engineers and Dr. Pyle, biostatistician) will help advance my
career in this field. The findings of the proposed study will generate essential data to propose an R01 focused
on therapeutic strategies to reduce osteoporosis risk in T1D.
摘要
患有1型糖尿病(T1 D)的绝经后女性发生髋部骨折的风险高出6至8倍
与没有糖尿病的女性相比。髋关节骨折与显著的发病率、死亡率、
独立性和经济负担。此外,糖尿病患者的髋部骨折死亡率更高
与无糖尿病的受试者相比。双能X线吸收测定法(DXA),最常见的测试,以评估
骨健康,仅测量骨矿物质密度(BMD),无法提供骨质量信息;
因此,它低估了T1 D患者的骨折风险。因此,我们假设髋关节结构和
与对照组相比,绝经后T1 D妇女的骨组织材料质量将受到损害。
与总体假设一致,我们建议测定髋骨结构质量(vBMD,骨密度),
几何形状和骨强度)使用定量计算机断层扫描(QCT)和一种新的计算机
基于图像的技术(有限元分析)[目的1],并评价骨组织成分的差异
使用拉曼光谱、纳米压痕和
与年龄和BMI相比,绝经后T1 D女性的背散射电子显微镜检查[目的2]
无糖尿病的绝经后妇女。
随着护理的改善,T1 D患者的寿命更长,并且没有具体的预防方法,
治疗患有T1 D的老年人骨质疏松症。因此,这项研究将阐明可能的机制,
绝经后T1 D女性的骨脆性,长期目标是预防髋部骨折和相关
这一高风险人群的发病率。
拟议的K23奖将通过提供必要的支持,促进我向独立过渡; 1)
获得并巩固临床科学知识和转化研究技能; 2)培养专业
研究技能,3)发展独立研究的道路。为了实现我的职业目标,我
组建了一个导师团队,包括1)T1 D领域的专家Janet Snell-Bergeon博士,博士
并发症和流行病学,由美国国立卫生研究院资助了十多年;和2)温迪·柯尔特博士,博士,
他是骨代谢和衰老领域的资深科学家,三十多年来一直获得NIH的资助。在
此外,指导团队的专业知识(Chonchol博士,骨代谢领域的临床研究员,
Drs.卡彭特和弗格森,生物力学工程师和派尔博士,生物统计学家)将有助于提高我的
在这个领域的职业生涯。拟议研究的结果将产生必要的数据,以提出R 01重点
降低T1 D患者骨质疏松风险的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Viral N Shah其他文献
What is a normal glucose value?
正常血糖值是多少?
- DOI:
10.1016/s2213-8587(25)00023-3 - 发表时间:
2025-03-01 - 期刊:
- 影响因子:41.800
- 作者:
Viral N Shah;David Kerr - 通讯作者:
David Kerr
Viral N Shah的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Viral N Shah', 18)}}的其他基金
Volumetric bone density, geometry, strength and bone tissue material properties in type 1 diabetes
1 型糖尿病的体积骨密度、几何形状、强度和骨组织材料特性
- 批准号:
10376142 - 财政年份:2019
- 资助金额:
$ 16.72万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 16.72万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 16.72万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 16.72万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 16.72万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 16.72万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 16.72万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 16.72万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 16.72万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 16.72万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 16.72万 - 项目类别:
Research Grant














{{item.name}}会员




